Social Media Press Releases

RSS

Showing Press Releases with Tag: influenza vaccines

7/18/2011

FLUMIST® (INFLUENZA VACCINE LIVE, INTRANASAL) BEGINS SHIPPING

» read more
8/10/2010

POSITION ON SCHOOL-BASED INFLUENZA VACCINATION PROGRAMS

» read more
4/19/2010

MEDIMMUNE TO PRESENT 10 ABSTRACTS ON INFLUENZA AT 44th NATIONAL IMMUNIZATION CONFERENCE

» read more
10/30/2009

MedImmune to Present 4 Abstracts on RSV and Influenza at 47TH Annual IDSA Meeting

» read more
9/21/2009

MedImmune Receives U.S. Government Order for Additional 29 Million Doses of Nasal Spray Vaccine for 2009 H1N1 Influenza

» read more
8/20/2009

‘Don’t Play With the Flu’(TM) Campaign to Coach Families on Playing Defense Against Seasonal Flu

» read more
5/05/2009

FluMist® Shows Acceptable Safety Profile in Immunocompromised Children, According to New Findings Presented at Pediatric Academic Societies Annual Meeting

» read more
1/06/2009

MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza

» read more
9/24/2007

MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production

» read more
8/23/2007

MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production

» read more
6/14/2007

Medimmune Is Awarded Contract By U.S. Department Of Health and Human Services to Retrofit Manufacturing Facilities For Production of Pandemic Influenza Vaccines

» read more
3/29/2007

MedImmune Licenses Reverse Genetics Technology to sanofi pasteur for Use in Influenza Vaccine Production

» read more
3/16/2007

MedImmune Leases Human Genome Sciences Facility to Expand Cell Culture Influenza Vaccine Manufacturing Capabilities

» read more
12/20/2006

MedImmune Licenses Reverse Genetics Technology to CSL for Use in Influenza Vaccine Production

» read more
12/06/2006

MedImmune Reconfirms 2009 Financial Targets of $2 Billion in Revenues and $2.00 in Earnings Per Diluted Share, Excluding Share-Based Compensation Expense, at 2006 Analyst Day

» read more